Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

2013304 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 14, Issue 8, pp. 777-786

Field-Weighted Citation Impact: 34.59